Document Classification

Section Type: RESULTS

Text: After inclusion of other therapies received during the event in regression models, risk ratio effect estimates (RR ; (95 % CI)) were attenuated for aspirin (0. 66 ; (0. 58 to 0. 76) to 0. 91 (0. 80 to 1. 03)), non-aspirin antiplatelets (0. 74 ; (0. 59 to 0. 92) to 0. 92 (0. 72 to 1. 18)), IV-tPA (0. 50 ; (0. 41 to 0. 62) to 0. 65 (0. 52 to 0. 80)) and stents (0. 53 (0. 40 to 0. 69) to 0. 68 (0. 49 to 0. 94)).